Carelabs Co.,Ltd

KOSDAQ:A263700 Stock Report

Market Cap: ₩50.4b

CarelabsLtd Past Earnings Performance

Past criteria checks 0/6

CarelabsLtd's earnings have been declining at an average annual rate of -62.7%, while the Healthcare Services industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 3.5% per year.

Key information

-62.7%

Earnings growth rate

-61.9%

EPS growth rate

Healthcare Services Industry Growth16.7%
Revenue growth rate3.5%
Return on equity-26.7%
Net Margin-25.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

There Is A Reason Carelabs Co.,Ltd's (KOSDAQ:263700) Price Is Undemanding

Nov 12
There Is A Reason Carelabs Co.,Ltd's (KOSDAQ:263700) Price Is Undemanding

The Market Doesn't Like What It Sees From Carelabs Co.,Ltd's (KOSDAQ:263700) Revenues Yet

Aug 07
The Market Doesn't Like What It Sees From Carelabs Co.,Ltd's (KOSDAQ:263700) Revenues Yet

We Think CarelabsLtd (KOSDAQ:263700) Has A Fair Chunk Of Debt

Jun 12
We Think CarelabsLtd (KOSDAQ:263700) Has A Fair Chunk Of Debt

Carelabs Co.,Ltd (KOSDAQ:263700) Held Back By Insufficient Growth Even After Shares Climb 50%

Feb 27
Carelabs Co.,Ltd (KOSDAQ:263700) Held Back By Insufficient Growth Even After Shares Climb 50%

Revenue & Expenses Breakdown

How CarelabsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A263700 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2481,300-20,62577,1802,637
30 Jun 2480,502-24,32779,9013,068
31 Mar 2481,181-23,66282,3463,449
31 Dec 2381,827-24,47082,4523,811
30 Sep 2382,468-26,23281,9513,849
30 Jun 2385,203-24,46681,6973,583
31 Mar 2387,341-26,65982,7803,192
31 Dec 2287,607-26,12483,8412,767
30 Sep 2291,259-13,67985,2412,895
30 Jun 2293,658-8,17084,9793,033
31 Mar 2295,413-1,68282,9753,275
31 Dec 2193,9341,25379,9943,502
30 Sep 2189,8782,25175,5743,280
30 Jun 2185,3583,63571,2962,878
31 Mar 2179,5205,37765,9292,744
31 Dec 2076,6664,32962,0342,743
30 Sep 2073,4954,23459,2922,796
30 Jun 2071,2392,76157,2973,133
31 Mar 2070,6131,62656,9613,233
31 Dec 1968,30058356,5643,096
30 Sep 1966,4191,18956,5222,875
30 Jun 1964,4521,81955,1382,479
31 Mar 1958,3792,10950,1932,194
31 Dec 1854,3793,55446,1431,830
30 Sep 1849,5484,45340,0611,905
30 Jun 1845,0044,45635,8451,755
31 Mar 1842,6844,84933,4801,753
31 Dec 1739,3364,78830,9191,428
30 Sep 1737,3144,99929,867798
31 Dec 1618,5971,93516,3300

Quality Earnings: A263700 is currently unprofitable.

Growing Profit Margin: A263700 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A263700 is unprofitable, and losses have increased over the past 5 years at a rate of 62.7% per year.

Accelerating Growth: Unable to compare A263700's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A263700 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (20.4%).

Return on Equity

High ROE: A263700 has a negative Return on Equity (-26.75%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Carelabs Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jongsun ParkEugene Investment & Securities Co Ltd.